Inflammatory cells have diverse roles in ischemic brain injury, exerting both deleterious and protective effects.
A utophagy is an intracellular degradation process that is critical for cellular homeostasis. 1 Engulfment of cytoplasmic materials leads to the formation of the autophagosome, a double-membrane structure inside the cell. The autophagosome fuses with lysosomes, resulting in degradation of the materials within the cell. 1 Autophagy is important for sequestering and removing unnecessary cytosol, cytoplasmic organelles, or microbes within cells.
2 ATG5 (autophagy-related protein 5) is essential for autophagosome formation, and deficiency in ATG5 results in failure of autophagy. 3, 4 Autophagy was classically recognized as part of a survival mechanism during starvation and a host defense mechanism against infection. However, autophagy was recently found to sequester inflammatory mediators in the cell, and it is emerging as a key process that regulates inflammation. Autophagy can lower basal inflammasome activation and suppress tissue inflammation by continuously removing defunct mitochondria. 2 In the brain, autophagy is not only part of basal homeostatic cellular metabolism but is also induced by pathological conditions, including traumatic brain injury and stroke. [5] [6] [7] [8] By regulating inflammation, autophagy may play significant roles in the initial injury, secondary injury, and recovery after ischemic brain injury. Autophagy in ischemic stroke may be complex, and experimental studies have revealed conflicting findings. [8] [9] [10] [11] Autophagy may play different roles based on the cell types that undergo autophagy, the timing at which autophagy is modulated, or the severity of brain injury.
Deficiency in the autophagic processes in macrophages can exacerbate atherosclerosis and acute lung injury in mice by promoting a proinflammatory milieu. 14, 15 Autophagy in myeloid lineage cells, notably macrophages, prevents the excessive release of proinflammatory cytokines and suppresses oxidative stress and inflammasome activation. 16, 17 Therefore, we hypothesized that autophagy in myeloid lineage cells, including macrophages, is critical for controlling secondary injury after ischemic brain injury. To investigate the potential roles of myeloid lineage cell autophagy in the pathophysiology of ischemic stroke, especially relating to secondary brain injury and recovery, we used mice that have a deficiency in autophagy in myeloid lineage cells.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. Experiments were conducted in accordance with the guidelines and a protocol approved by the University of California, San Francisco, Institutional Animal Care and Use Committee.
Atg5flox/flox (Atg5 f/f ) mice were generous gifts from Dr Noboru Mizushima (University of Tokyo) 3 and LysMCre mice (B6.129P2-Lyz2tm1(cre)Ifo/J) 18 were purchased from the Jackson Laboratory (Bar Harbor, ME). Atg5 f/f mice were bred with Atg5 f/f LysMCre+ mice (mice carrying 1 allele of LysMCre) to create myeloid lineage cell-specific Atg5 deletion (Atg5 f/f LysMCre+ mice carrying 1 allele of LysMCre) and control littermates (Atg5 f/f mice not carrying a LysMCre allele). LysMCre deletes floxed genes in myeloid lineage cells, including macrophages and granulocytes. [18] [19] [20] LysMCre has a low recombination efficacy in microglia in vivo 20 reported as <10% to 25%. [20] [21] [22] [23] We induced transient focal cerebral ischemia using the left transient middle cerebral artery occlusion (MCAO) as previously described by others. 24, 25 Animals were euthanized at 12 hours, 3 days, and 7 days after reperfusion. We assessed infarct volume, neurological deficits, immune cell infiltration, and inflammatory cytokine mRNA expression as previously described. [26] [27] [28] [29] [30] [31] [32] [33] [34] Details of the methods are presented in the online-only Data Supplement.
Statistical Analysis
Two-way ANOVA or 2-way ANOVA followed by Bonferroni multiple comparisons test when applicable was used for comparison of continuous variables. The ordinal scores (neurological deficit score and grip test score) were analyzed by the Mann-Whitney test. Survival rate was analyzed by log-rank test. For infarct volume, we calculated a sample size to detect the difference between 40% and 60% in infarct volume assuming α of 0.05, power of 0.8, and SD of 10% (G*Power 3.1.9.3). Statistical analyses were performed using Prism 6 software (GraphPad Software, San Diego, CA). P<0.05 was considered statistically significant. Continuous variables are presented as the mean±SD, and ordinal scores are presented as the range; median.
Results

Survival and Initial Injury After Ischemic Stroke in Atg5flox/flox LysMCre+ Mice
As a first step, we assessed 14-day survival rates after 60-minute MCAO in myeloid lineage-specific ATG5 knockout mice (Atg5 f/f LysMCre+) and their control littermates (Atg5 f/f ). As shown in Figure 1A , myeloid lineage cell-specific ATG5 knockout mice (myeloid ATG5 knockout) had a significantly lower survival rate than control mice (20% versus 70%; P<0.05).
To test whether the lower survival rate in myeloid ATG5 knockout mice was because of a more severe initial injury after MCAO, we assessed the degree of initial injury by measuring infarct volume and neurological deficit score at 12 hours after 60-minute MCAO. As shown in Figure 1B and 1C, there were no significant differences in the infarct volume (46%±12% versus 44%±9% hemisphere: mean±SD; P=0.73) or neurological deficit score (1-3; 2 versus 1-2; 2, range; median; P>0.99) between myeloid ATG5 knockout mice and control littermates, indicating no difference in the initial injury.
Secondary Injury After Ischemic Stroke in Mice Lacking Autophagy in Myeloid Lineage Cells
As shown above, the mortality of myeloid ATG5 knockout mice after 60-minute ischemia was 80%, making it impossible to examine the potential mechanisms by which the lack of autophagy in myeloid lineage cells worsens the outcome after ischemic stroke. Therefore, in the next series of experiments, we induced 30-minute ischemia (ie, mild injury). We examined infarct volume, neurological functions, and inflammatory cell infiltration at 12 hours, 3 days, and 7 days after MCAO. There was no difference in the overall survival between myeloid ATG5 knockout mice and control littermates (79% versus 85%; n=14 versus 13; P=0.66) 7 days after 30-minute ischemia.
When the initial injury was assessed 12 hours after 30-minute MCAO, similar to the 60-minute occlusion, there was no significant difference in infarct volume (50%±9% versus 42%±7% hemisphere; P=0. 19) , neurological deficit score (2-3; 2 versus 1-3; 2, range; median; P>0.99), or grip test score (0-3; 3 versus 0-4; 0, range; median; P=0.68; Figure 2 ) between myeloid ATG5 knockout mice and control littermates, 
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again indicating that the lack of myeloid cell autophagy did not affect injury early after stroke.
In contrast, as shown in Figure 3 , when mice were examined at later time points (days 3 and 7) after 30-minute MCAO, myeloid-specific ATG5 knockout mice had significantly worse neurological deficit scores than control mice (day 3: 0-2; 2 versus 0-1; 1, range; median, P<0.0005; day 7: 0-2; 1 versus 0-1; 1, range; median, P<0.05). Similarly, at 3 and 7 days after 30-minute MCAO, myeloid ATG5 knockout mice showed lower grip test scores than control mice ( In addition, myeloid ATG5 knockout mice had significantly larger infarct volumes than control mice at day 3 (55%±12% versus 38%±9% hemisphere; P<0.05) and at day 7 (55%±4% versus 39%±12% hemisphere; P<0.05) whether analyzed pairwise or analyzing all 4 groups together ( Figure 3A ). There was no difference in infarct volume between day 3 and day 7 in each group. These data indicate that the lack of autophagy in myeloid cells worsens the secondary injury after ischemic stroke.
Inflammatory Cell Infiltration
To investigate the underlying mechanism by which the lack of autophagy in myeloid lineage cells worsens secondary injury after ischemic stroke, we first assessed Lys6G-positive cells, CD68-positive cells, and ionized calcium binding adaptor molecule 1 (Iba1)-positive cells in the peri-infarct area at 12 hours, 3 days, and 7 days after 30-minute MCAO. Thirtyminute MCAO caused a significant increase in the number of both CD68-positive cells and Lys6G-positive cells in the periinfarct area in both myeloid ATG5 knockout mice and control mice at all 3 time points (Figure 4) . However, there was no difference in the number of CD68-positive cells or Lys6G-positive infiltrating cells in the peri-infarct area between myeloid ATG5 knockout mice and control mice at any time point (Figure 4A and 4B) .
Although Figure 4C ). We also assessed M1 and M2 polarization as previously described. [35] [36] [37] [38] [39] There was no difference in M1 or M2 markerpositive cells between myeloid ATG5 knockout mice and control mice at 12 hours after MCAO (online-only Data Supplement). At later time points, numbers of both M1 and M2 marker-positive cells increased. However, the increase was more pronounced in M1 marker-positive cells than in M2 marker-positive cells. Seven days after MCAO, myeloid ATG5 knockout mice had a significantly higher number of M1 marker-positive cells than control mice (online-only Data Supplement). In contrast, there was no significant difference in the number of M2 marker-positive cells between myeloid ATG5 knockout mice and control mice at any time point.
Inflammatory Cytokines in the Infarcted Hemisphere
The mRNA expression levels of inflammatory cytokines in the infarcted hemisphere (ipsilateral) and the contralateral hemisphere were assessed by real-time polymerase chain reaction 12 hours, 3 days, and 7 days after 30-minute MCAO. At all 3 time points, the infarcted hemisphere had significantly higher levels of interleukin-1β, tumor necrosis factor-α, interleukin-6, matrix metalloproteinase-9, and monocyte chemotactic protein-1 than the contralateral hemisphere ( Figure 5) .
When the mRNA levels of the infarcted hemisphere were compared between myeloid ATG5 knockout and control mice, there was no difference in any of these cytokines at the early time point (12 hours). However, at the later time points (3 and 7 days), myeloid ATG5 knockout mice showed higher expression of interleukin-1β ( 
Discussion
In this study, we found that a lack of autophagy in myeloid lineage cells, including macrophages and neutrophils, did not affect the initial infarct volume or neurological score measured at 12 hours; however, it worsened long-term survival after 60-minute ischemia. Similarly, when the 30-minute ischemia model was used, there was no difference in the infarct volume or neurological outcomes at 12 hours after 30-minute ischemia between myeloid lineage cell-specific ATG5 knockout mice and control mice; however, myeloid lineage cellspecific ATG5 knockout mice had larger infarct volumes and worse neurological outcomes at later time points, specifically 3 and 7 days. These observations indicate that autophagy in myeloid lineage cells plays an important role in controlling secondary injury and potentially promoting recovery after ischemic brain injury.
Autophagy in myeloid lineage cells may play several roles after ischemic brain injury. Shortly after brain ischemia, myeloid lineage cells, including macrophages and neutrophils, can be attracted to the infarcted area and the surrounding penumbra and release proinflammatory cytokines; the resulting inflammation promotes further injury. It was not surprising that we found no effect of myeloid lineage cell autophagy deficiency on the initial infarct volume as the initial damage may be primarily a function of the primary brain ischemia caused by the lack of cerebral blood flow. Moreover, it is possible that the lack of autophagy does not affect the ability of macrophages and neutrophils to home and infiltrate into the injury site as a part of the initial inflammatory response.
The LysM Cre driver is highly efficient in recombining genes in macrophages and monocytes [40] [41] [42] and has been shown to cause gene recombination in granulocytes. [43] [44] [45] Although LysM Cre seems reliable in recombining target genes in cultured microglia, recombination by LysM Cre driver in microglia in vivo not efficient, [20] [21] [22] [23] reported as <10% to 25%. [21] [22] [23] Therefore, it is more likely that the worse outcomes after ischemic stroke observed in this study in Atg5f/f LysMCre+ mice are because of the lack of autophagy in macrophages, monocytes, and possibly granulocytes. However, we cannot completely exclude a possible contribution of the lack of ATG5 in a small subset of microglia to the worse outcomes. There are likely several mechanisms by which autophagy in myeloid lineage cells affects secondary injury and recovery after ischemic brain injury. By effectively removing endogenous inflammasome activators, including reactive oxygen species and defunct mitochondria DNA, 2,46 autophagy may suppress the overall inflammasome activity and reduce the secondary injury that is partly mediated by sustained and aberrant inflammation in the penumbra. In addition, efferocytosis-the removal of dead or abnormal cells-during the resolution of inflammation may be defective in macrophages lacking autophagy, 14, 47 resulting in excessive inflammation during the subacute and chronic phases after ischemic brain injury. Alternatively, a lack of autophagic death of macrophages and neutrophils may cause persistent inflammation by effectively slowing the resolution of the initial inflammation. Our findings on M1 and M2 polarization indicate that the lack of autophagy in myeloid lineage cells promotes M1 polarization. Increased M1 polarization during recovery from stroke may lead to sustained inflammation, likely contributing to the worse long-term neurological outcomes and mortality in myeloid lineage-specific ATG5 knockout mice. Although the precise mechanism by which autophagy deficiency in myeloid lineage cells leads to worse long-term survival and neurological outcomes in this model is unknown, the increased M1 polarization further supports more severe inflammation in myeloid lineage cell-specific ATG5 knockout mice than in control mice after ischemic brain injury.
Promotion or enhancement of autophagy in myeloid lineage cells after brain ischemia may have therapeutic potential for improving stroke outcomes. However, autophagy in other cell types may have different roles. There are conflicting reports on the effects of indiscriminate modulation of autophagy in stroke models, 13, [48] [49] [50] probably reflecting differential roles of autophagy in different cell types. The roles of autophagy after stroke are likely dependent on the cell type, severity of injury, and timing. 16 In this study, we assessed infarct volumes at 12 hours, 3 days, and 7 days after ischemic stroke. It has been reported that the core infarct rapidly expands and becomes complete by 6 to 12 hours after 30 minutes of MCAO in mice. [51] [52] [53] Further expansion of the infarct after 12 hours is thought to reflect expanding ischemic damage in the penumbra. 51, 53 Therefore, the time point at 12 hours is appropriate to assess the potential role of autophagy in the initial and early injury in this model. Although some of the subacute or delayed damage may occur 1 or 2 days after ischemia, previous studies indicated that there were no significant changes in infarct volume between 24 hours and 3 days after 30 minutes of MCAO in mice. 53, 54 Therefore, our data at 3 days are sufficient in assessing possible subacute or delayed damages. Nevertheless, assessment of infarct volumes at more frequent time points may be useful in further characterizing dynamic changes in the absence of myeloid lineage autophagy in ischemic stroke.
Although some of the past studies have used Iba1 and CD68 as a microglial and macrophage maker, respectively, some fractions of microglia seem to express CD68 and infiltrating monocytes/macrophages in the brain may express Iba1. [55] [56] [57] Therefore, these markers may not be able to distinguish infiltrating macrophages from microglias. 58 Recent reports suggest that transmembrane protein 119 may act as a specific marker for microglia and that an antibody against transmembrane protein 119 does cross-react with infiltrating monocytes/macrophages. 59 For future studies, generation of chimeric mice or the adoptive transfer of monocyte/macrophage populations may be needed to precisely distinguish these 2 cell types.
Although serial imaging using magnetic resonance imaging or computed tomography could be useful in longitudinally assessing evolution of infarct volume, 60, 61 here we assessed infarct volume at multiple time points using Cresyl violet staining. Infarct volume measured by histological methods closely correlates with that determined by magnetic resonance imaging, 60, 61 and Cresyl violet staining is established as a highly reliable method to measure infarct volume, especially studies assessing longterm outcomes. [62] [63] [64] Further characterization of roles of myeloid cell autophagy may be aided by the use of serial imaging using magnetic resonance imaging or computed tomography. Another limitation of this study is that we used relatively young male mice to study the roles of autophagy of myeloid lineage cells in ischemic stroke. Our intention was to explore the potential role of myeloid cell lineage autophagy in ischemic stroke, thus using animals of both sexes and of different ages is beyond the scope of the present study. Ultimately, these additional important biological variables will need to be tested.
Summary
The lack of autophagy in myeloid linage cells decreased survival and aggravated secondary injury after ischemic stroke, with higher levels of proinflammatory cytokines. Our findings indicate that autophagy in myeloid cells plays a protective role in ischemic injury and may be a potential therapeutic target. 
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